Teva reports falling Copaxone sales, sharp rise in 40mg use

– Sales of the multiple sclerosis treatment were down 12% in the second quarter. – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) reported higher profit and revenue in its financial More...